Global Opioid Induced Side Effects Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4759467
- 85 Pages
- January 2022
- Pharmaceuticals
The United States Opioid Induced Side Effects Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Opioid Induced Side Effects Treatment market, reaching US$ million by the year 2028. As for the Europe Opioid Induced Side Effects Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Opioid Induced Side Effects Treatment players cover Shionogi, Cubist Pharmaceuticals, SLA Pharma, and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Induced Side Effects Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Risperidone
Methylphenidate
Cetirizine
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Drug Overdose Treatment
Pain Treatment
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Shionogi
Cubist Pharmaceuticals
SLA Pharma
AstraZeneca
AIKO Biotechnology
Progenics Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioid Induced Side Effects Treatment Market Size 2017-2028
2.1.2 Opioid Induced Side Effects Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Opioid Induced Side Effects Treatment Segment by Type
2.2.1 Risperidone
2.2.2 Methylphenidate
2.2.3 Cetirizine
2.2.4 Other
2.3 Opioid Induced Side Effects Treatment Market Size by Type
2.3.1 Opioid Induced Side Effects Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2022)
2.4 Opioid Induced Side Effects Treatment Segment by Application
2.4.1 Drug Overdose Treatment
2.4.2 Pain Treatment
2.4.3 Other
2.5 Opioid Induced Side Effects Treatment Market Size by Application
2.5.1 Opioid Induced Side Effects Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2022)
3 Opioid Induced Side Effects Treatment Market Size by Player
3.1 Opioid Induced Side Effects Treatment Market Size Market Share by Players
3.1.1 Global Opioid Induced Side Effects Treatment Revenue by Players (2020-2022)
3.1.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Opioid Induced Side Effects Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Opioid Induced Side Effects Treatment by Regions
4.1 Opioid Induced Side Effects Treatment Market Size by Regions (2017-2022)
4.2 Americas Opioid Induced Side Effects Treatment Market Size Growth (2017-2022)
4.3 APAC Opioid Induced Side Effects Treatment Market Size Growth (2017-2022)
4.4 Europe Opioid Induced Side Effects Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Opioid Induced Side Effects Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Opioid Induced Side Effects Treatment Market Size by Country (2017-2022)
5.2 Americas Opioid Induced Side Effects Treatment Market Size by Type (2017-2022)
5.3 Americas Opioid Induced Side Effects Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Induced Side Effects Treatment Market Size by Region (2017-2022)
6.2 APAC Opioid Induced Side Effects Treatment Market Size by Type (2017-2022)
6.3 APAC Opioid Induced Side Effects Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Opioid Induced Side Effects Treatment by Country (2017-2022)
7.2 Europe Opioid Induced Side Effects Treatment Market Size by Type (2017-2022)
7.3 Europe Opioid Induced Side Effects Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opioid Induced Side Effects Treatment by Region (2017-2022)
8.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Opioid Induced Side Effects Treatment Market Forecast
10.1 Global Opioid Induced Side Effects Treatment Forecast by Regions (2023-2028)
10.1.1 Global Opioid Induced Side Effects Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Opioid Induced Side Effects Treatment Forecast
10.1.3 APAC Opioid Induced Side Effects Treatment Forecast
10.1.4 Europe Opioid Induced Side Effects Treatment Forecast
10.1.5 Middle East & Africa Opioid Induced Side Effects Treatment Forecast
10.2 Americas Opioid Induced Side Effects Treatment Forecast by Country (2023-2028)
10.2.1 United States Opioid Induced Side Effects Treatment Market Forecast
10.2.2 Canada Opioid Induced Side Effects Treatment Market Forecast
10.2.3 Mexico Opioid Induced Side Effects Treatment Market Forecast
10.2.4 Brazil Opioid Induced Side Effects Treatment Market Forecast
10.3 APAC Opioid Induced Side Effects Treatment Forecast by Region (2023-2028)
10.3.1 China Opioid Induced Side Effects Treatment Market Forecast
10.3.2 Japan Opioid Induced Side Effects Treatment Market Forecast
10.3.3 Korea Opioid Induced Side Effects Treatment Market Forecast
10.3.4 Southeast Asia Opioid Induced Side Effects Treatment Market Forecast
10.3.5 India Opioid Induced Side Effects Treatment Market Forecast
10.3.6 Australia Opioid Induced Side Effects Treatment Market Forecast
10.4 Europe Opioid Induced Side Effects Treatment Forecast by Country (2023-2028)
10.4.1 Germany Opioid Induced Side Effects Treatment Market Forecast
10.4.2 France Opioid Induced Side Effects Treatment Market Forecast
10.4.3 UK Opioid Induced Side Effects Treatment Market Forecast
10.4.4 Italy Opioid Induced Side Effects Treatment Market Forecast
10.4.5 Russia Opioid Induced Side Effects Treatment Market Forecast
10.5 Middle East & Africa Opioid Induced Side Effects Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Opioid Induced Side Effects Treatment Market Forecast
10.5.2 South Africa Opioid Induced Side Effects Treatment Market Forecast
10.5.3 Israel Opioid Induced Side Effects Treatment Market Forecast
10.5.4 Turkey Opioid Induced Side Effects Treatment Market Forecast
10.5.5 GCC Countries Opioid Induced Side Effects Treatment Market Forecast
10.6 Global Opioid Induced Side Effects Treatment Forecast by Type (2023-2028)
10.7 Global Opioid Induced Side Effects Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Shionogi
11.1.1 Shionogi Company Information
11.1.2 Shionogi Opioid Induced Side Effects Treatment Product Offered
11.1.3 Shionogi Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Shionogi Main Business Overview
11.1.5 Shionogi Latest Developments
11.2 Cubist Pharmaceuticals
11.2.1 Cubist Pharmaceuticals Company Information
11.2.2 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Offered
11.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cubist Pharmaceuticals Main Business Overview
11.2.5 Cubist Pharmaceuticals Latest Developments
11.3 SLA Pharma
11.3.1 SLA Pharma Company Information
11.3.2 SLA Pharma Opioid Induced Side Effects Treatment Product Offered
11.3.3 SLA Pharma Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 SLA Pharma Main Business Overview
11.3.5 SLA Pharma Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Opioid Induced Side Effects Treatment Product Offered
11.4.3 AstraZeneca Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Information
11.5.2 AIKO Biotechnology Opioid Induced Side Effects Treatment Product Offered
11.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AIKO Biotechnology Main Business Overview
11.5.5 AIKO Biotechnology Latest Developments
11.6 Progenics Pharmaceuticals
11.6.1 Progenics Pharmaceuticals Company Information
11.6.2 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Offered
11.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Progenics Pharmaceuticals Main Business Overview
11.6.5 Progenics Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Opioid Induced Side Effects Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Risperidone
Table 3. Major Players of Methylphenidate
Table 4. Major Players of Cetirizine
Table 5. Major Players of Other
Table 6. Opioid Induced Side Effects Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2022)
Table 9. Opioid Induced Side Effects Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2022)
Table 12. Global Opioid Induced Side Effects Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Opioid Induced Side Effects Treatment Revenue Market Share by Player (2020-2022)
Table 14. Opioid Induced Side Effects Treatment Key Players Head office and Products Offered
Table 15. Opioid Induced Side Effects Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Opioid Induced Side Effects Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Opioid Induced Side Effects Treatment Market Size Market Share by Regions (2017-2022)
Table 20. Americas Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Opioid Induced Side Effects Treatment Market Size Market Share by Country (2017-2022)
Table 22. Americas Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2022)
Table 24. Americas Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2022)
Table 26. APAC Opioid Induced Side Effects Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Opioid Induced Side Effects Treatment Market Size Market Share by Region (2017-2022)
Table 28. APAC Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2022)
Table 30. APAC Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2022)
Table 32. Europe Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Country (2017-2022)
Table 34. Europe Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2022)
Table 36. Europe Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Opioid Induced Side Effects Treatment Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Opioid Induced Side Effects Treatment
Table 45. Key Market Challenges & Risks of Opioid Induced Side Effects Treatment
Table 46. Key Industry Trends of Opioid Induced Side Effects Treatment
Table 47. Global Opioid Induced Side Effects Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Opioid Induced Side Effects Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Opioid Induced Side Effects Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Opioid Induced Side Effects Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Opioid Induced Side Effects Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Opioid Induced Side Effects Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 53. Shionogi Details, Company Type, Opioid Induced Side Effects Treatment Area Served and Its Competitors
Table 54. Shionogi Opioid Induced Side Effects Treatment Product Offered
Table 55. Shionogi Opioid Induced Side Effects Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Shionogi Main Business
Table 57. Shionogi Latest Developments
Table 58. Cubist Pharmaceuticals Details, Company Type, Opioid Induced Side Effects Treatment Area Served and Its Competitors
Table 59. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Offered
Table 60. Cubist Pharmaceuticals Main Business
Table 61. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Cubist Pharmaceuticals Latest Developments
Table 63. SLA Pharma Details, Company Type, Opioid Induced Side Effects Treatment Area Served and Its Competitors
Table 64. SLA Pharma Opioid Induced Side Effects Treatment Product Offered
Table 65. SLA Pharma Main Business
Table 66. SLA Pharma Opioid Induced Side Effects Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. SLA Pharma Latest Developments
Table 68. AstraZeneca Details, Company Type, Opioid Induced Side Effects Treatment Area Served and Its Competitors
Table 69. AstraZeneca Opioid Induced Side Effects Treatment Product Offered
Table 70. AstraZeneca Main Business
Table 71. AstraZeneca Opioid Induced Side Effects Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. AstraZeneca Latest Developments
Table 73. AIKO Biotechnology Details, Company Type, Opioid Induced Side Effects Treatment Area Served and Its Competitors
Table 74. AIKO Biotechnology Opioid Induced Side Effects Treatment Product Offered
Table 75. AIKO Biotechnology Main Business
Table 76. AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. AIKO Biotechnology Latest Developments
Table 78. Progenics Pharmaceuticals Details, Company Type, Opioid Induced Side Effects Treatment Area Served and Its Competitors
Table 79. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Offered
Table 80. Progenics Pharmaceuticals Main Business
Table 81. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Progenics Pharmaceuticals Latest Developments
List of Figures
Figure 1. Opioid Induced Side Effects Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Opioid Induced Side Effects Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Opioid Induced Side Effects Treatment Market Size Market Share by Type in 2021
Figure 7. Opioid Induced Side Effects Treatment in Drug Overdose Treatment
Figure 8. Global Opioid Induced Side Effects Treatment Market: Drug Overdose Treatment (2017-2022) & ($ Millions)
Figure 9. Opioid Induced Side Effects Treatment in Pain Treatment
Figure 10. Global Opioid Induced Side Effects Treatment Market: Pain Treatment (2017-2022) & ($ Millions)
Figure 11. Opioid Induced Side Effects Treatment in Other
Figure 12. Global Opioid Induced Side Effects Treatment Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Opioid Induced Side Effects Treatment Market Size Market Share by Application in 2021
Figure 14. Global Opioid Induced Side Effects Treatment Revenue Market Share by Player in 2021
Figure 15. Global Opioid Induced Side Effects Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Opioid Induced Side Effects Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Opioid Induced Side Effects Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Opioid Induced Side Effects Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Opioid Induced Side Effects Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Opioid Induced Side Effects Treatment Value Market Share by Country in 2021
Figure 21. Americas Opioid Induced Side Effects Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Opioid Induced Side Effects Treatment Market Size Market Share by Application in 2021
Figure 23. United States Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Opioid Induced Side Effects Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Opioid Induced Side Effects Treatment Market Size Market Share by Application in 2021
Figure 29. China Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Opioid Induced Side Effects Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Opioid Induced Side Effects Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Opioid Induced Side Effects Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Opioid Induced Side Effects Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Opioid Induced Side Effects Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
